Literature DB >> 20692431

Left ventricular pressure measurement by telemetry is an effective means to evaluate transplanted heart function in experimental heterotopic cardiac xenotransplantation.

K A Horvath1, P C Corcoran, A K Singh, R F Hoyt, C Carrier, M L Thomas, M M Mohiuddin.   

Abstract

Evaluation of the function of heterotopic cardiac transplants has traditionally been accomplished by either manual palpation or serial biopsies. Both methods have drawbacks. Palpation can be difficult to differentiate a pulse from the graft versus a transmitted pulse from the native aorta. Serial biopsies, though accurate, require multiple laparotomies, leading to increased morbidity and possibly mortality rates. In this study we used an advanced telemetry system, consisting of an intra-abdominal implant, that was capable of continuously monitoring simultaneously several parameters of the transplanted heart and the status of the recipient. In a large animal model of heterotopic cardiac xenotransplantation (pig donor to baboon recipient), we implanted the device in 12 animals: 8 with and 4 without immunosuppression. We monitored and continuously recorded the left ventricular pressure (both peak-systolic and end-diastolic [LVEDP]), heart rate, and the electrocardiogram pattern of the transplanted heart as well as the temperature of the recipient. The left ventricular pressure proved to be the most valuable parameter to assess graft heart function. In the 4 nonimmunosuppressed cases, grafts were rejected acutely. In these cases, the end-diastolic pressure increased sharply and the heart stopped contracting when the difference between the systolic and the diastolic pressure decreased to <10 mm Hg. The earliest reproducible sign of rejection was an increased LVEDP. Among long-term survivors, the increase in diastolic pressure was gradual, indicating progressive thickening of the myocardium and decreased compliance of the ventricle. Six of 8 immunosuppressed animals died of other complications before rejecting the transplanted heart. The telemetry was also helpful to indicate early onset of fever in the recipients, thus allowing us to intervene early and prevent potentially lethal septic complications. Continuous monitoring of several parameters via telemetry allowed detection of changes associated with rejection as well as other complications at an early stage, allowing prompt intervention, treatment, and possibly reversal of rejection. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692431      PMCID: PMC2919493          DOI: 10.1016/j.transproceed.2010.05.117

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Noninvasive detection of cardiac allograft rejection by prospective telemetric monitoring.

Authors:  J S Pirolo; T S Shuman; E M Brunt; M J Liptay; J L Cox; T B Ferguson
Journal:  J Thorac Cardiovasc Surg       Date:  1992-05       Impact factor: 5.209

2.  Telemetric detection of cardiac allograft rejection. Correlation of electrophysiological, histological, and biochemical changes during unmodified rejection.

Authors:  K Koike; P S Hesslein; H K Dasmahapatra; G J Wilson; C D Finlay; S L David; S Kielmanowicz; J G Coles
Journal:  Circulation       Date:  1988-09       Impact factor: 29.690

3.  Endpoint detection of heterotopic grafted rat hearts using an implanted transmitter.

Authors:  W H Groeneveld; W J Kort
Journal:  J Surg Res       Date:  1981-07       Impact factor: 2.192

4.  Technique for heterotopic pig heart xenotransplantation in primates.

Authors:  D H Adams; R H Chen; A Kadner; S Naficy
Journal:  Ann Thorac Surg       Date:  1999-07       Impact factor: 4.330

5.  Monitoring pig-to-primate cardiac xenografts with live Internet images of recipients and xenograft telemetric signals: histologic and immunohistochemical correlations.

Authors:  R H Chen; A Kadner; D H Adams
Journal:  J Heart Lung Transplant       Date:  2000-06       Impact factor: 10.247

  5 in total
  7 in total

1.  The road to the first FDA-approved genetically engineered pig heart transplantation into human.

Authors:  Avneesh K Singh; Bartley P Griffith; Corbin E Goerlich; David Ayares; Muhammad M Mohiuddin
Journal:  Xenotransplantation       Date:  2022-09-20       Impact factor: 3.788

2.  Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation.

Authors:  Muhammad M Mohiuddin; Avneesh K Singh; Philip C Corcoran; Robert F Hoyt; Marvin L Thomas; David Ayares; Keith A Horvath
Journal:  J Thorac Cardiovasc Surg       Date:  2014-06-06       Impact factor: 5.209

3.  Circulating cell-free DNA as a biomarker of tissue injury: Assessment in a cardiac xenotransplantation model.

Authors:  Sean Agbor-Enoh; Joshua L Chan; Avneesh Singh; Ilker Tunc; Sasha Gorham; Jun Zhu; Mehdi Pirooznia; Philip C Corcoran; Marvin L Thomas; Billeta G T Lewis; Moon Kyoo Jang; David L Ayares; Keith A Horvath; Muhammad M Mohiuddin; Hannah Valantine
Journal:  J Heart Lung Transplant       Date:  2018-04-26       Impact factor: 10.247

4.  The growth of xenotransplanted hearts can be reduced with growth hormone receptor knockout pig donors.

Authors:  Corbin E Goerlich; Bartley Griffith; Peter Hanna; Susie N Hong; David Ayares; Avneesh K Singh; Muhammad M Mohiuddin
Journal:  J Thorac Cardiovasc Surg       Date:  2021-09-04       Impact factor: 5.209

5.  Perioperative Telemetric Monitoring in Pig-to-Baboon Heterotopic Thoracic Cardiac Xenotransplantation.

Authors:  Matthias Längin; Alessandro Panelli; Bruno Reichart; Alexander Kind; Paolo Brenner; Tanja Mayr; Jan-Michael Abicht
Journal:  Ann Transplant       Date:  2018-07-20       Impact factor: 1.530

6.  Intra-Abdominal Heterotopic Cardiac Xenotransplantation: Pearls and Pitfalls.

Authors:  Laura DiChiacchio; Avneesh K Singh; Joshua L Chan; Nicole M Shockcor; Tianshu Zhang; Billeta G Lewis; David Ayares; Philip Corcoran; Keith A Horvath; Muhammad M Mohiuddin
Journal:  Front Cardiovasc Med       Date:  2019-07-25

7.  Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft.

Authors:  Muhammad M Mohiuddin; Avneesh K Singh; Philip C Corcoran; Marvin L Thomas Iii; Tannia Clark; Billeta G Lewis; Robert F Hoyt; Michael Eckhaus; Richard N Pierson Iii; Aaron J Belli; Eckhard Wolf; Nikolai Klymiuk; Carol Phelps; Keith A Reimann; David Ayares; Keith A Horvath
Journal:  Nat Commun       Date:  2016-04-05       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.